Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma. Meeting Abstract

cited authors

  • Jain, Rohit K.; Yang, Yuanquan; Chadha, Juskaran; Chatwal, Monica Sheila; Kish, Julie Ann; Raymond, Sarah; Rembisz, Jennifer; Jameel, Ghazal; Mustasam, Arfa; Poehlman, Trey; Fan, Wenyi; Kim, Youngchul; Dhillon, Jasreman; Alemany, Carlos A.; Mortazavi, Amir; Zhang, Jingsong; Sonpavde, Guru P.

Publication Date

  • February 20, 2023

webpage

published in

category

volume

  • 41